The DOI matches its Crossref record; 540 of the 540 references it cites were found in a registry or an index.
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Open accessAbstract
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the presence of one or more cardiometabolic risk factor(s) and the absence of harmful alcohol intake. The spectrum of MASLD includes steatosis, metabolic dysfunction-associated steatohepatitis (MASH, previously NASH), fibrosis, cirrhosis and MASH-related hepatocellular carcinoma (HCC). This joint EASL-EASD-EASO guideline provides an update on definitions, prevention, screening, diagnosis and treatment for MASLD. Case-finding strategies for MASLD with liver fibrosis, using non-invasive tests, should be applied in individuals with cardiometabolic risk factors, abnormal liver enzymes, and/or radiological signs of hepatic steatosis, particularly in the presence of type 2 diabetes (T2D) or obesity with additional metabolic risk factor(s). A stepwise approach using blood-based scores (such as FIB-4) and, sequentially, imaging techniques (such as transient elastography) is suitable to rule-out/in advanced fibrosis, which is predictive of liver-related outcomes. In adults with MASLD, lifestyle modification – including weight loss, dietary changes, physical exercise and discouraging alcohol consumption – as well as optimal management of comorbidities – including use of incretin-based therapies (e.g. semaglutide, tirzepatide) for T2D or obesity, if indicated – is advised. Bariatric surgery is also an option in individuals with MASLD and obesity. If locally approved and dependent on the label, adults with non-cirrhotic MASH and significant liver fibrosis (stage ≥2) should be considered for a MASH-targeted treatment with resmetirom, which demonstrated histological effectiveness on steatohepatitis and fibrosis with an acceptable safety and tolerability profile. No MASH-targeted pharmacotherapy can currently be recommended for the cirrhotic stage. Management of MASH-related cirrhosis includes adaptations of metabolic drugs, nutritional counselling, surveillance for portal hypertension and HCC, as well as liver transplantation in decompensated cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–540 of 540
PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date
Cherubini, A., Casirati, E., Tomasi, M., & Valenti, L. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.2018418 · Cited by 79
Bariatric surgery improves nonalcoholic fatty liver disease: systematic review and meta-analysis
Zhou, H., Luo, P., Li, P., wang, G., Yi, X., Fu, Z., Sun, X., Cui, B., Zhu, L., & Zhu, S. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06011-1 · Cited by 79
Wong, G. L., Chan, H. L., Choi, P. C., Chan, A. W., Lo, A. O., Chim, A. M., & Wong, V. W. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.09.025 · Cited by 79
Selective Agonists of Thyroid Hormone Receptor Beta for the Treatment of NASH
Cusi, K. (2024) · New England Journal of Medicine · doi:10.1056/nejme2314365 · Cited by 78
Oh, S., Tsujimoto, T., Kim, B., Uchida, F., Suzuki, H., Iizumi, S., Isobe, T., Sakae, T., Tanaka, K., & Shoda, J. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100253 · Cited by 77
Definition of healthy ranges for alanine aminotransferase levels: a 2021 update
Valenti, L., Pelusi, S., Bianco, C., Ceriotti, F., Berzuini, A., Iogna Prat, L., Trotti, R., Malvestiti, F., D’Ambrosio, R., Lampertico, P., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1794 · Cited by 77
Galvin, Z., Rajakumar, R., Chen, E., Adeyi, O., Selzner, M., Grant, D., Sapisochin, G., Greig, P., Cattral, M., McGilvray, I., et al. (2019) · Liver Transplantation · doi:10.1002/lt.25338 · Cited by 76
Harrison, S. A., Manghi, F. P., Smith, W. B., Alpenidze, D., Aizenberg, D., Klarenbeek, N., Chen, C.-Y., Zuckerman, E., Ravussin, E., Charatcharoenwitthaya, P., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01861-9 · Cited by 75
Vilar-Gomez, E., Lou, Z., Kong, N., Vuppalanchi, R., Imperiale, T. F., & Chalasani, N. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.017 · Cited by 75
Malespin, M. H., Barritt, A. S., Watkins, S. E., Schoen, C., Tincopa, M. A., Corbin, K. D., Mospan, A. R., Munoz, B., Trinh, H. N., Weiss, L. M., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.01.023 · Cited by 75
Reddy, K. R., McLerran, D., Marsh, T. L., Parikh, N. D., Roberts, L. R., Schwartz, M., Nguyen, M. H., Befeler, A. S., Page-Lester, S., Tang, R., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.06.027 · Cited by 75
Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease
VanWagner, L. B., Ning, H., Allen, N. B., Ajmera, V., Lewis, C. E., Carr, J. J., Lloyd-Jones, D. M., Terrault, N. A., & Siddique, J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.012 · Cited by 74
Simons, N., Veeraiah, P., Simons, P. I., Schaper, N. C., Kooi, M. E., Schrauwen-Hinderling, V. B., Feskens, E. J., van der Ploeg, E. (., Van den Eynde, M. D., Schalkwijk, C. G., et al. (2021) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa332 · Cited by 74
Glucagon-like Peptide-1 Receptor Agonist Use in Patients With Liver Cirrhosis and Type 2 Diabetes
Yen, F.-S., Hou, M.-C., Cheng-Chung Wei, J., Shih, Y.-H., Hsu, C. Y., Hsu, C.-C., & Hwu, C.-M. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.06.004 · Cited by 73
Schneider, C. V., Zandvakili, I., Thaiss, C. A., & Schneider, K. M. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100263 · Cited by 73
Should patients with NAFLD/NASH Be surveyed for HCC?
Reig, M., Gambato, M., Man, N. K., Roberts, J. P., Victor, D., Orci, L. A., & Toso, C. (2019) · Transplantation · doi:10.1097/tp.0000000000002361 · Cited by 71
Jarvis, H., O'Keefe, H., Craig, D., Stow, D., Hanratty, B., & Anstee, Q. M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-049767 · Cited by 71
Zhang, S., Gu, Y., Bian, S., Lu, Z., Zhang, Q., Liu, L., Meng, G., Yao, Z., Wu, H., Wang, Y., et al. (2021) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa380 · Cited by 70
Post-transplant obesity impacts long-term survival after liver transplantation
van Son, J., Stam, S. P., Gomes-Neto, A. W., Osté, M. C. J., Blokzijl, H., van den Berg, A. P., Porte, R. J., Bakker, S. J. L., & de Meijer, V. E. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154204 · Cited by 70
Tamaki, N., Ahlholm, N., Luukkonen, P. K., Porthan, K., Sharpton, S. R., Ajmera, V., Kono, Y., Dave, S., Ahmed, A., Sundaram, V., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci162513 · Cited by 69
Ma, Y., Yang, W., Li, T., Liu, Y., Simon, T. G., Sui, J., Wu, K., Giovannucci, E. L., Chan, A. T., & Zhang, X. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz146 · Cited by 69
Baker, C. J., Martinez‐Huenchullan, S. F., D'Souza, M., Xu, Y., Li, M., Bi, Y., Johnson, N. A., & Twigg, S. M. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13086 · Cited by 69
AGA Clinical Practice Guidelines on Intragastric Balloons in the Management of Obesity
Muniraj, T., Day, L. W., Teigen, L. M., Ho, E. Y., Sultan, S., Davitkov, P., Shah, R., & Murad, M. H. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.03.003 · Cited by 69
Tapper, E. B., Hunink, M. G. M., Afdhal, N. H., Lai, M., & Sengupta, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147237 · Cited by 68
Tsamalaidze, L., Stauffer, J. A., Arasi, L. C., Villacreses, D. E., Franco, J. S. S., Bowers, S., & Elli, E. F. (2018) · Obesity Surgery · doi:10.1007/s11695-017-2847-7 · Cited by 67
Tamaki, N., Imajo, K., Sharpton, S. R., Jung, J., Kawamura, N., Yoneda, M., Valasek, M. A., Behling, C. A., Sirlin, C. B., Nakajima, A., et al. (2021) · Hepatology · doi:10.1002/hep.32145 · Cited by 66
Zhu, C., Boucheron, N., Müller, A. C., Májek, P., Claudel, T., Halilbasic, E., Baazim, H., Lercher, A., Viczenczova, C., Hainberger, D., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.06.036 · Cited by 65
Ebrahimi, F., Hagström, H., Sun, J., Bergman, D., Shang, Y., Yang, W., Roelstraete, B., & Ludvigsson, J. F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.018 · Cited by 65
Kalavalapalli, S., Leiva, E. G., Lomonaco, R., Chi, X., Shrestha, S., Dillard, R., Budd, J., Romero, J. P., Li, C., Bril, F., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac660 · Cited by 64
Elsaid, M. I., Li, Y., Bridges, J. F. P., Brock, G., Minacapelli, C. D., & Rustgi, V. K. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.35003 · Cited by 63
Åberg, F., Färkkilä, M., & Männistö, V. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14271 · Cited by 63
Implementation of a liver health check in people with type 2 diabetes
Abeysekera, K. W. M., Valenti, L., Younossi, Z., Dillon, J. F., Allen, A. M., Noureddin, M., Rinella, M. E., Tacke, F., Francque, S., Ginès, P., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00270-4 · Cited by 63
Zhang, X., Song, J., Zhang, Y., Wen, B., Dai, L., Xi, R., Wu, Q., Li, Y., Luo, X., Lan, X., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.10.030 · Cited by 62
Castéra, L., Garteiser, P., Laouenan, C., Vidal-Trécan, T., Vallet‐Pichard, A., Manchon, P., Paradis, V., Czernichow, S., Roulot, D. M., Larger, É., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.03.023 · Cited by 62
Bhurwal, A., Ratta, P., Yoshitake, S., Pioppo, L., Reja, D., Dellatore, P., & Rustgi, V. (2020) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-805 · Cited by 61
Metabolic syndrome traits increase the risk of major adverse liver outcomes in type 2 diabetes
Shang, Y., Grip, E. T., Modica, A., Skröder, H., Ström, O., Ntanios, F., Gudbjörnsdottir, S., & Hagström, H. (2024) · Diabetes Care · doi:10.2337/dc23-1937 · Cited by 61
Henry, A., Paik, J. M., Austin, P., Eberly, K. E., Golabi, P., Younossi, I., Henry, L., Gerber, L., & Younossi, Z. M. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17308 · Cited by 61
Wijarnpreecha, K., Li, F., Lundin, S. K., Suresh, D., Song, M. W., Tao, C., Chen, V. L., & Lok, A. S. F. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17424 · Cited by 61
Outcomes of sleeve gastrectomy in obese liver transplant candidates
Sharpton, S. R., Terrault, N. A., & Posselt, A. M. (2019) · Liver Transplantation · doi:10.1002/lt.25406 · Cited by 60
Chun, H. S., Lee, M., Lee, H. A., Oh, S. Y., Baek, H. J., Moon, J. W., Kim, Y. J., Lee, J., Kim, H., Kim, H. Y., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.043 · Cited by 60
Rosso, C., Caviglia, G. P., Birolo, G., Armandi, A., Pennisi, G., Pelusi, S., Younes, R., Liguori, A., Perez-Diaz-del-Campo, N., Nicolosi, A., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.04.024 · Cited by 59
Management of metabolic syndrome and cardiovascular risk after liver transplantation
Fatourou, E. M., & Tsochatzis, E. A. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30181-5 · Cited by 59
Kennedy, O. J., Fallowfield, J. A., Poole, R., Hayes, P. C., Parkes, J., & Roderick, P. J. (2021) · BMC Public Health · doi:10.1186/s12889-021-10991-7 · Cited by 58
Schön, M., Prystupa, K., Mori, T., Zaharia, O. P., Bódis, K., Bombrich, M., Möser, C., Yurchenko, I., Kupriyanova, Y., Strassburger, K., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00329-7 · Cited by 58
Simon, T. G., Kim, M. N., Luo, X., Yang, W., Ma, Y., Chong, D. Q., Fuchs, C. S., Meyerhardt, J. A., Corey, K. E., Chung, R. T., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.022 · Cited by 57
Xiao, J., Ng, C. H., Chan, K. E., Fu, C., Tay, P., Yong, J. N., Lim, W. H., Tan, D. J. H., Syn, N., Wong, Z. Y., et al. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.11.006 · Cited by 56
Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
Koning, M., Herrema, H., Nieuwdorp, M., & Meijnikman, A. S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2226922 · Cited by 56
Cassinotto, C., Boursier, J., Paisant, A., Guiu, B., Irles‐Depe, M., Canivet, C., Aube, C., & de Ledinghen, V. (2021) · Hepatology · doi:10.1002/hep.31655 · Cited by 55
Bril, F., Barb, D., Lomonaco, R., Lai, J., & Cusi, K. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.018 · Cited by 55
Zhang, X., Yip, T. C.-F., Wong, G. L.-H., Leow, W.-X., Liang, L. Y., Lim, L.-L., Li, G., Ibrahim, L., Lin, H., Lai, J. C. T., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-330269 · Cited by 55
Qadri, S., Vartiainen, E., Lahelma, M., Porthan, K., Tang, A., Idilman, I. S., Runge, J. H., Juuti, A., Penttilä, A. K., Dabek, J., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2023.100928 · Cited by 55
VanWagner, L. B., Holl, J. L., Montag, S., Gregory, D., Connolly, S., Kosirog, M., Campbell, P., Pine, S., Daud, A., Finn, D., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15706 · Cited by 55
Body composition and overweight of liver transplant recipients
Anastácio, L. R., Ferreira, L. G., de Sena Ribeiro, H., Lima, A. S., Garcia Vilela, E., & Toulson Davisson Correia, M. I. (2011) · Transplantation · doi:10.1097/tp.0b013e31822e0bee · Cited by 54
Marin‐Alejandre, B. A., Cantero, I., Perez‐Diaz‐del‐Campo, N., Monreal, J. I., Elorz, M., Herrero, J. I., Benito‐Boillos, A., Quiroga, J., Martinez‐Echeverria, A., Uriz‐Otano, J. I., et al. (2021) · Liver International · doi:10.1111/liv.14818 · Cited by 54
Park, W. Y., Yiannakou, I., Petersen, J. M., Hoffmann, U., Ma, J., & Long, M. T. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.11.001 · Cited by 53
Eslam, M., Wong, G. L.-H., Hashem, A. M., Chan, H. L.-Y., Nielsen, M. J., Leeming, D. J., Chan, A. W.-H., Chen, Y., Duffin, K. L., Karsdal, M., et al. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001059 · Cited by 53
Bogumil, D., Park, S., Le Marchand, L., Haiman, C. A., Wilkens, L. R., Boushey, C. J., & Setiawan, V. W. (2019) · Hepatology Communications · doi:10.1002/hep4.1313 · Cited by 52
Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease
Hagström, H., Kechagias, S., & Ekstedt, M. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13343 · Cited by 52
Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease
Lin, H., Yip, T. C., Zhang, X., Li, G., Tse, Y., Hui, V. W., Liang, L. Y., Lai, J. C., Chan, S. L., Chan, H. L., et al. (2023) · Hepatology · doi:10.1002/hep.32633 · Cited by 52
Metabolic syndrome and its association with nonalcoholic steatohepatitis
Bril, F., Sanyal, A., & Cusi, K. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.002 · Cited by 52
Kim, M. N., Lo, C.-H., Corey, K. E., Luo, X., Long, L., Zhang, X., Chan, A. T., & Simon, T. G. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.12.014 · Cited by 51
Andreeva, V. A., Egnell, M., Touvier, M., Galan, P., Julia, C., & Herçberg, S. (2021) · Central European Journal of Public Health · doi:10.21101/cejph.a6239 · Cited by 51
Meta-analysis: enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases
Hinkson, A., Lally, H., Gibson, H., Jones, R., Rowe, I. A., Shinkins, B., & Parker, R. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17385 · Cited by 51
Cornberg, M., Tacke, F., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.011 · Cited by 49
One size does not fit all; practical, personal tailoring of the diet to NAFLD patients
Zelber‐Sagi, S., Grinshpan, L. S., Ivancovsky‐Wajcman, D., Goldenshluger, A., & Gepner, Y. (2022) · Liver International · doi:10.1111/liv.15335 · Cited by 49
Bischoff, S. C., Ockenga, J., Eshraghian, A., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Kani, H. T., Khannoussi, W., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.03.021 · Cited by 49
SGLT2 Inhibitors in Liver Patients
Hsiang, J. C., & Wong, V. W.-S. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.05.021 · Cited by 48
Jaroenlapnopparat, A., Charoenngam, N., Ponvilawan, B., Mariano, M., Thongpiya, J., & Yingchoncharoen, P. (2023) · Menopause · doi:10.1097/gme.0000000000002133 · Cited by 48
Gitto, S., Maria, N. D., Benedetto, F. D., Tarantino, G., Serra, V., Maroni, L., Cescon, M., Pinna, A. D., Schepis, F., Andreoné, P., et al. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001105 · Cited by 48
Jamali, T., Raasikh, T., Bustamante, G., Sisson, A., Tandon, P., Duarte-Rojo, A., & Hernaez, R. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001883 · Cited by 47
Community socioeconomic deprivation predicts nonalcoholic steatohepatitis
Giammarino, A. M., Qiu, H., Bulsara, K., Khan, S., Jiang, Y., Da, B. L., Bernstein, D. E., & Satapathy, S. K. (2022) · Hepatology Communications · doi:10.1002/hep4.1831 · Cited by 47
Coffee consumption is associated with lower liver stiffness: a nationally representative study
Niezen, S., Mehta, M., Jiang, Z. G., & Tapper, E. B. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.09.042 · Cited by 47
Relationships between education and non-alcoholic fatty liver disease
Koutny, F., Aigner, E., Datz, C., Gensluckner, S., Maieron, A., Mega, A., Iglseder, B., Langthaler, P., Frey, V., Paulweber, B., et al. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.07.039 · Cited by 46
Chow, J. C., Wong, G. L., Chan, A. W., Shu, S. S., Chan, C. K., Leung, J. K., Choi, P. C., Chim, A. M., Chan, H. L., & Wong, V. W. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14311 · Cited by 46
Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis
Buzzetti, E., Linden, A., Best, L. M., Madden, A. M., Roberts, D., Chase, T. J. G., Freeman, S. C., Cooper, N. J., Sutton, A. J., Fritche, D., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013156.pub2 · Cited by 46
Yoneda, M., Thomas, E., Sumida, Y., Eguchi, Y., & Schiff, E. R. (2014) · Hepatology · doi:10.1002/hep.27097 · Cited by 45
Delayed sleeve gastrectomy following liver transplantation: a 5-year experience
Morris, M. C., Jung, A. D., Kim, Y., Lee, T. C., Kaiser, T. E., Thompson, J. R., Bari, K., Shah, S. A., Cohen, R. M., Schauer, D. P., et al. (2019) · Liver Transplantation · doi:10.1002/lt.25637 · Cited by 45
Munteanu, M., Pais, R., Peta, V., Deckmyn, O., Moussalli, J., Ngo, Y., Rudler, M., Lebray, P., Charlotte, F., Thibault, V., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14990 · Cited by 42
Fraser, D. A., Wang, X., Lund, J., Nikolić, N., Iruarrizaga-Lejarreta, M., Skjaeret, T., Alonso, C., Kastelein, J. J. P., Rustan, A. C., Kim, Y. O., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.004 · Cited by 41
Liu, Y., Yang, W., VoPham, T., Ma, Y., Simon, T. G., Gao, X., Chan, A. T., Meyerhardt, J. A., Giovannucci, E. L., & Zhang, X. (2021) · Hepatology · doi:10.1002/hep.31251 · Cited by 40
Vilar-Gomez, E., Vuppalanchi, R., Gawrieh, S., Pike, F., Samala, N., & Chalasani, N. (2023) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002222 · Cited by 39
Phisalprapa, P., Supakankunti, S., Charatcharoenwitthaya, P., Apisarnthanarak, P., Charoensak, A., Washirasaksiri, C., Srivanichakorn, W., & Chaiyakunapruk, N. (2017) · Medicine · doi:10.1097/md.0000000000006585 · Cited by 39
Hughes, D. M., Berhane, S., Emily de Groot, C. A., Toyoda, H., Tada, T., Kumada, T., Satomura, S., Nishida, N., Kudo, M., Kimura, T., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.084 · Cited by 39
Wong, V. W., Anstee, Q. M., Nitze, L. M., Geerts, A. M., George, J., Nolasco, V., Kjær, M. S., Ladelund, S., Newsome, P. N., & Ratziu, V. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102310 · Cited by 39
Sinn, D. H., Kang, D., Cho, S. J., Paik, S. W., Guallar, E., Cho, J., & Gwak, G.-Y. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002158 · Cited by 37
Yoo, J.-J., Park, M. Y., Cho, E. J., Yu, S. J., Kim, S. G., Kim, Y. J., Kim, Y. S., & Yoon, J.-H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093336 · Cited by 36
Meena, B. L., Taneja, S., Tandon, P., Sahni, N., Soundararajan, R., Gorsi, U., De, A., Verma, N., Premkumar, M., Duseja, A., et al. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16035 · Cited by 36
Behari, J., Gougol, A., Wang, R., Luu, H. N., Paragomi, P., Yu, Y.-C., Molinari, M., Chopra, K., Malik, S. M., Geller, D., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000183 · Cited by 35
Luu, H. N., Neelakantan, N., Geng, T., Wang, R., Goh, G. B., Clemente, J. C., Jin, A., van Dam, R. M., Jia, W. P., Behari, J., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33367 · Cited by 35
Truong, E., GORNBEIN, J. A., Yang, J. D., Noureddin, N., Harrison, S. A., Alkhouri, N., & Noureddin, M. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.02.003 · Cited by 35
Differences in the association of diet quality with body fat distribution between men and women
Maskarinec, G., Namatame, L. A., Kang, M., Buchthal, S. D., Ernst, T., Monroe, K. R., Shepherd, J. A., Wilkens, L. R., Boushey, C. J., Marchand, L. L., et al. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0563-1 · Cited by 34
Advancing diagnosis and management of liver disease in adults through exome sequencing
Zheng, M., Hakim, A., Konkwo, C., Deaton, A. M., Ward, L. D., Silveira, M. G., Assis, D. N., Liapakis, A., Jaffe, A., Jiang, Z. G., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104747 · Cited by 34
Managing diabetes in patients with chronic liver disease
Khan, R., Foster, G. R., & Chowdhury, T. A. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.07.2574 · Cited by 34
Metabolic complications in liver transplantation recipients: how we can optimize long-term survival
Azhie, A., Sheth, P., Hammad, A., Woo, M., & Bhat, M. (2021) · Liver Transplantation · doi:10.1002/lt.26219 · Cited by 34
Scorletti, E., Creasy, K. T., Vujkovic, M., Vell, M., Zandvakili, I., Rader, D. J., Schneider, K. M., & Schneider, C. V. (2022) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001726 · Cited by 33
Luu, H. N., Behari, J., Goh, G. B.-B., Wang, R., Jin, A., Thomas, C. E., Clemente, J. C., Odegaard, A. O., Koh, W.-P., & Yuan, J.-M. (2021) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1201 · Cited by 33
Soldera, J., Camazzola, F., Rodríguez, S., & Brandão, A. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i11.877 · Cited by 33
Cardiovascular disease outcomes related to early stage renal impairment after liver transplantation
VanWagner, L. B., Montag, S., Zhao, L., Allen, N. B., Lloyd-Jones, D. M., Das, A., Skaro, A. I., Hohmann, S., Friedewald, J. J., & Levitsky, J. (2018) · Transplantation · doi:10.1097/tp.0000000000002175 · Cited by 32
Liu, Z., Huang, H., Zeng, Y., Chen, Y., & Xu, C. (2023) · British Journal Of Nutrition · doi:10.1017/s0007114522003956 · Cited by 32
Julián, M. T., Ballesta, S., Pera, G., Pérez-Montes de Oca, A., Soldevila, B., Caballería, L., Morillas, R., Expósito, C., Martínez–Escudé, A., Puig-Domingo, M., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1051958 · Cited by 30
Zhang, J., Fu, S., Liu, D., Wang, Y., & Tan, Y. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002517 · Cited by 27
Kashiwagi, K., Yamaguchi, A., Shiba, S., Taniki, N., Inoue, N., Takaishi, H., Iwao, Y., & Kanai, T. (2020) · Alcohol · doi:10.1016/j.alcohol.2020.07.010 · Cited by 26
Physical activity and risk of hepatocellular carcinoma: a systematic review and meta-analysis
DiJoseph, K., Thorp, A., Harrington, A., Schmitz, K. H., Chinchilli, V. M., & Stine, J. G. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07601-w · Cited by 25
The association of nonalcoholic steatohepatitis and obstructive sleep apnea
Asfari, M. M., Niyazi, F., Lopez, R., Dasarathy, S., & McCullough, A. J. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000973 · Cited by 25
Pryke, R., & Guha, I. N. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.10.010 · Cited by 25
Sherry, A. P., Willis, S. A., Yates, T. E., Johnson, W., Razieh, C., Sargeant, J. A., Malaikah, S., Stensel, D. J., Aithal, G. P., & King, J. A. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100622 · Cited by 25
Josef, P., Ali, I., Ariel, P., Alon, M., & Nimer, A. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10083409 · Cited by 22
Peng, X., Li, J., Zhao, H., Lai, J., Lin, J., & Tang, S. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01015-5 · Cited by 22
Ren, M., Zhou, X., Zhang, Y., Mo, F., Yang, J., Yu, M., & Ji, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.931519 · Cited by 22
Evaluation of recipients with significant comorbidity - patients with cardiovascular disease
Tsochatzis, E. A., Watt, K. D., VanWagner, L. B., Verna, E. C., & Berzigotti, A. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.023 · Cited by 22
Combined liver transplantation and sleeve gastrectomy: report of a brief-interval staged approach
Tariq, N., Saharia, A., Nwokedi, U., Hobeika, M. J., Mobley, C. M., Hsu, D., Potter, L. M., Moore, L. W., Elaileh, A., Sherman, V., et al. (2023) · Liver Transplantation · doi:10.1002/lt.26560 · Cited by 21
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis
Komolafe, O., Buzzetti, E., Linden, A., Best, L. M., Madden, A. M., Roberts, D., Chase, T. J., Fritche, D., Freeman, S. C., Cooper, N. J., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013157.pub2 · Cited by 21
Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: A population-based cohort study
Ciardullo, S., Cannistraci, R., Muraca, E., Zerbini, F., & Perseghin, G. (2024) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.11.011 · Cited by 20
Pillai, S., Duvvuru, S., Bhatnagar, P., Foster, W., Farmen, M., Shankar, S., Harris, C., Bastyr, E., Hoogwerf, B., & Haupt, A. (2018) · The Pharmacogenomics Journal · doi:10.1038/tpj.2017.45 · Cited by 19
Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: a case series
Pelusi, S., Ronzoni, L., Malvestiti, F., Bianco, C., Marini, I., D'Ambrosio, R., Giannotta, J. A., Soardo, G., Maggioni, M., Prati, D., et al. (2022) · Liver International · doi:10.1111/liv.15185 · Cited by 18
Watt, K. D., Heimbach, J. K., Rizk, M., Jaruvongvanich, P., Sanchez, W., Port, J., Venkatesh, S. K., Bamlet, H., Tiedtke, K., Malhi, H., et al. (2021) · Liver Transplantation · doi:10.1002/lt.26074 · Cited by 18
Combined sleeve gastrectomy with liver transplant in patients with obesity: a feasibility study
Gunturu, N. S., Castillo-Larios, R., Bowers, S., Edwards, M., Burns, J., Perry, D., & Elli, E. F. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06289-1 · Cited by 17
Huang, Y., Wang, Y., Xiao, Z., Yao, S., Tang, Y., Zhou, L., Wang, Q., Xie, Y., Zhang, L., Zhou, Y., et al. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03580-6 · Cited by 16
Prevalence and determinants of liver disease in relatives of Italian patients with advanced MASLD
Pelusi, S., Ronzoni, L., Rondena, J., Rosso, C., Pennisi, G., Dongiovanni, P., Margarita, S., Carpani, R., Soardo, G., Prati, D., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.12.033 · Cited by 16
Verna, E. C., Phipps, M. M., Halazun, K. J., Markovic, D., Florman, S. S., Haydel, B. M., Ruiz, R., Klintmalm, G., Lee, D. D., Taner, B., et al. (2023) · Liver Transplantation · doi:10.1097/lvt.0000000000000007 · Cited by 16
Cardio‐hepatic risk assessment by CMR imaging in liver transplant candidates
Reddy, S. T., Thai, N. L., Oliva, J., Tom, K. B., Dishart, M. K., Doyle, M., Yamrozik, J. A., Williams, R. B., Shah, M., Wani, A., et al. (2018) · Clinical Transplantation · doi:10.1111/ctr.13229 · Cited by 16
External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population
Åström, H., Ndegwa, N., & Hagström, H. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100343 · Cited by 16
Chen, G., Banini, B. A., Do, A., Gunderson, C., Zaman, S., & Lim, J. K. (2023) · Genes · doi:10.3390/genes14091811 · Cited by 15
Linden-Torres, E., Zambrano-Galván, G., Sahebkar, A., Ríos-Mier, M., & Simental-Mendía, L. E. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.07.010 · Cited by 15
Listing practices for morbidly obese patients at liver transplantation centers in the United States
(2016) · Experimental and Clinical Transplantation · doi:10.6002/ect.2015.0247 · Cited by 15
Vijayaraghavan, R., Sarin, S. K., Bharadwaj, A., Anand, L., Maiwall, R., Choudhury, A., Benjamin, J., Kanal, U., & Jamwal, K. D. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07596-4 · Cited by 15
Pais, R., Cariou, B., Noureddin, M., Francque, S., Schattenberg, J. M., Abdelmalek, M. F., Lalazar, G., Varma, S., Dietrich, J., Miller, V., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.014 · Cited by 15
Anushiravani, A., Alswat, K., Dalekos, G. N., Zachou, K., Örmeci, N., Al-Busafi, S., Abdo, A., Sanai, F., Mikhail, N. N., Soliman, R., et al. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002641 · Cited by 14
Sharma, B. C., Maharshi, S., Sachdeva, S., Mahajan, B., Sharma, A., Bara, S., Srivastava, S., Kumar, A., Dalal, A., & Sonika, U. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16266 · Cited by 11
Zhou, G.-P., Jiang, Y.-Z., Sun, L.-Y., & Zhu, Z.-J. (2022) · International Journal of Surgery · doi:10.1016/j.ijsu.2022.106752 · Cited by 10
Ratziu, V., & Tacke, F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.003 · Cited by 10
Yip, T. C., Chan, R. N. C., Wong, V. W., Tse, Y., Liang, L. Y., Hui, V. W., Zhang, X., Li, G., Chan, H. L., & Wong, G. L. (2021) · Health Science Reports · doi:10.1002/hsr2.352 · Cited by 9
Toyoda, H., Fujii, H., Iwaki, M., Hayashi, H., Oeda, S., Hyogo, H., Kawanaka, M., Morishita, A., Munekage, K., Kawata, K., et al. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.07.018 · Cited by 9
Bradley, C. R., Cox, E. F., Palaniyappan, N., Aithal, G. P., Francis, S. T., & Guha, I. N. (2022) · European Radiology Experimental · doi:10.1186/s41747-022-00303-y · Cited by 8
Measuring lipoprotein(a) for cardiovascular disease prevention – in whom and when?
Thomas, P. E., Vedel‐Krogh, S., & Nordestgaard, B. G. (2023) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001104 · Cited by 8
Sharma, S., Stine, J. G., Verbeek, T., & Bezinover, D. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.07.020 · Cited by 5
Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting
Balitzer, D., Tsai, J.-H., & Gill, R. M. (2022) · Diagnostic Pathology · doi:10.1186/s13000-022-01247-y · Cited by 5
Lee, D. U., Han, J., Lee, K. J., Kwon, J., Fan, G. H., Jung, D., & Urrunaga, N. H. (2022) · Hepatology International · doi:10.1007/s12072-022-10414-8 · Cited by 4
935 VISCERAL FAT AS A STRONG AND INDEPENDENT RISK FACTOR OF NONALCOHOLIC FATTY LIVER DISEASE
Kim, D., Park, B., Kim, W., Jung, Y.-S., Kim, Y. J., Yoon, J.-H., Kim, J. L., & Lee, H. S. (2008) · Journal of Hepatology · doi:10.1016/s0168-8278(08)60937-x · Cited by 4
Yen, F., Hwu, C., & Hsu, C. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.10.018 · Cited by 1
Research works printed but not linked: 1
- 10.1042/0264-6021:3480607 · DOI · Paper page
Cited by
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
Hagström, H., Shang, Y., Hegmar, H., & Nasr, P. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00193-6 · Cited by 310
Metabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W. S., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki-Järvinen, H., & Loomba, R. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 293
Nadolsky, K., Garvey, W. T., Agarwal, M., Bonnecaze, A., Burguera, B., Chaplin, M. D., Griebeler, M. L., Harris, S. R., Schellinger, J. N., Simonetti, J., et al. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.017 · Cited by 141
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update
Pedersen, S. D., Manjoo, P., Dash, S., Jain, A., Pearce, N., & Poddar, M. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.250502 · Cited by 78
Metadata
- Authors
- European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO)
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2024
- Volume
- 17
- Issue
- 4
- Pages
- 374-444
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- OpenAlex
- W4399420682
- Cited by
- 471
- References
- 540
- FWCI
- 123.15
- Type
- journal article
- Language
- en
- Update notices
- erratum (2024-06-07)
- Open access
- gold
- Licence
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.